These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 6260876)

  • 1. The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs.
    Field H; McMillan A; Darby G
    J Infect Dis; 1981 Feb; 143(2):281-5. PubMed ID: 6260876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
    Schinazi RF; Nahmias AJ
    Am J Med; 1982 Jul; 73(1A):40-8. PubMed ID: 6285731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
    Coen DM; Fleming HE; Leslie LK; Retondo MJ
    J Virol; 1985 Feb; 53(2):477-88. PubMed ID: 2982032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Methoxymethyldeoxyuridine-resistant mutants of herpes simplex virus type 1.
    Veerisetty V; Gentry GA
    Virology; 1981 Oct; 114(2):576-9. PubMed ID: 6270889
    [No Abstract]   [Full Text] [Related]  

  • 5. Herpes simplex acyclovir-resistant mutant in experimental keratouveitis.
    Boisjoly HM; Park NH; Pavan-Langston D; De Clercq E
    Arch Ophthalmol; 1983 Nov; 101(11):1782-6. PubMed ID: 6314952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses.
    Ayisi NK; Gupta SV; Babiuk LA
    Antiviral Res; 1985 Feb; 5(1):13-27. PubMed ID: 2984988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Wilber BA; Docherty JJ
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1743-7. PubMed ID: 8021603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1.
    Coen DM; Schaffer PA; Furman PA; Keller PM; St Clair MH
    Am J Med; 1982 Jul; 73(1A):351-60. PubMed ID: 6285722
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.
    Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ
    Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease.
    Charles SJ; Gray JJ
    Br J Ophthalmol; 1990 May; 74(5):286-8. PubMed ID: 2162190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus.
    Field HJ; Darby G; Wildy P
    J Gen Virol; 1980 Jul; 49(1):115-24. PubMed ID: 6252285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
    Saijo M; Suzutani T; Yoshida I
    Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of herpes simplex virus to adenine arabinoside and E-5-(2-bromovinyl)-2'-deoxyuridine: a physical analysis.
    Crumpacker CS; Schnipper LE; Kowalsky PN; Sherman DM
    J Infect Dis; 1982 Aug; 146(2):167-72. PubMed ID: 6286786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of phosphonoformic acid-resistant herpes simplex virus variants to arabinosylnucleosides and aphidicolin.
    Bastow KF; Derse DD; Cheng YC
    Antimicrob Agents Chemother; 1983 Jun; 23(6):914-7. PubMed ID: 6311091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplicity dependence and sensitivity of herpes simplex virus isolates to antiviral compounds.
    Harmenberg J; Wahren B; Sundqvist VA; Levén B
    J Antimicrob Chemother; 1985 May; 15(5):567-73. PubMed ID: 2989239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation.
    Ljungman P; Ellis MN; Hackman RC; Shepp DH; Meyers JD
    J Infect Dis; 1990 Jul; 162(1):244-8. PubMed ID: 2162368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Resistance of herpes simplex viruses to antiviral drugs].
    Scieux C; Bianchi A
    Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome.
    Birch CJ; Tachedjian G; Doherty RR; Hayes K; Gust ID
    J Infect Dis; 1990 Sep; 162(3):731-4. PubMed ID: 2167340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir.
    Crumpacker CS; Schnipper LE; Marlowe SI; Kowalsky PN; Hershey BJ; Levin MJ
    N Engl J Med; 1982 Feb; 306(6):343-6. PubMed ID: 6275267
    [No Abstract]   [Full Text] [Related]  

  • 20. [Development of resistance of herpes simplex virus to antivirus drugs in vitro].
    Chen ZJ; Liu WG; Song JZ
    Yao Xue Xue Bao; 1992; 27(1):10-4. PubMed ID: 1382356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.